Abstract: The present invention relates to a nucleic acid molecule encoding a human or canine GABAB receptor, or a conservative variant thereof.

Abstract: A device including a display for displaying indicia, comprising: control means 900 for controlling the display 57, the control means having a memory 810 for storing control data, wherein said control means is configured so as to be responsive to said stored control data to provide indicia on said display; a voltage source 64 for providing a voltage to the device; sensing means 1300 configured to disable the display in response to variation of the voltage provided to the device beyond a threshold value; and means 1200 configured so as to be responsive to a control signal 1203 and prevent the disabling of the display by the control means, wherein said control signal 1203 is applied externally to the device.

Abstract: The invention provides the use of formoterol and budesonide in the treatment of chronic obstructive pulmonary disease.

Abstract: A device for displaying indicia, comprising: a display 57 comprising a plurality of activatable elements, wherein each element has an activated state in which the element is visible and a deactivated state in which the element is not visible and one or more of the elements are activatable to display indicia; and control means 910 for controlling the display 57 which includes test means 960 which is configured to activate successively groups of elements according to a predetermined control sequence such that the activated and deactivated state of each of the elements is tested, wherein the control means 910 is configured to activate the elements in groups of one or two and the successive activation of elements comprises, for each group, the steps of activating all of the elements in the group, activating one element in the group, not activating one element in the group and not activating all of the elements in the group.

Abstract: A new metered unit dose comprising 40 &mgr;g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.